This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust Europe | 29 Jul 2021

( July 29, 2021, 07:32 GMT | Press Round-Up Europe) -- Contents: - Advanz fined in UK over thyroid drug pricing - Bionext claims unfair large-scale testing competition - Monsanto fined in France for data protection malpractice - Bloom & Wild buys French flower rival Bergamotte - AKKA Technologies to merge with Modis consultancy - VW-led consortium set to acquire Europcar - Airbus faces opposition to Premium Aerotec sale - Cinven buys majority stake in RB Iberia - Cum-Ex trades equal tax evasion, German court says- The UK Competition and Markets Authority has imposed more than 100 million pounds in fines on Advanz, after the company inflated the price of thyroid tablets, causing the NHS and patients to lose out....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login